semaglutide prediabetes weight loss trial progression to diabetes 2025 ADA Highlights: A New Era for GLP-1 Therapies in Obesity and SCALE (NEJM 2015) was the

The shortage question Compounding of tirzepatide has been legally available primarily during periods when the brand-name product was listed on the FDA drug shortage list

Understanding which supplements to take with tirzepatide helps maintain nutritional adequacy during treatment

In people with NAION, blood flow to the optic nerve gets reduced or blocked, leading to sudden vision loss

It is important to distinguish between side effects directly attributable to the medication's pharmacological action and those arising from the broader context of weight management

Any significant deviation from the initial appearancesuch as darkening, fading, cloudiness, or particle formationshould prompt immediate contact with the compounding pharmacy before administration

Visit fda.gov/medwatch or call 1-800-FDA-1088